Clinical Trial Update: Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tenecteplase for late-window acute ischemic stroke guided by DWI-FLAIR mismatch; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING